Analysis of Predictive Biomarkers in Patients With Lung Adenocarcinoma From Southern Brazil Reveals a Distinct Profile From Other Regions of the Country

PURPOSE: Adenocarcinoma is the most common histologic subtype of non–small-cell lung cancer, representing 40% of all diagnoses. Several biomarkers are currently used to determine patient eligibility for targeted treatments, including analysis of molecular alterations in EGFR and ALK, as well as prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreis, Tiago F., Correa, Bruno S., Vianna, Fernanda S., De-Paris, Fernanda, Siebert, Marina, Leistner-Segal, Sandra, Hahn, Eriza C., Ulbrich, Jane M., Rivero, Luis F.R., De Oliveira, Francine H., Lorandi, Vinícius, Ashton-Prolla, Patricia, Macedo, Gabriel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872182/
https://www.ncbi.nlm.nih.gov/pubmed/31532708
http://dx.doi.org/10.1200/JGO.19.00174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872182/
https://www.ncbi.nlm.nih.gov/pubmed/31532708
http://dx.doi.org/10.1200/JGO.19.00174

Ejemplares similares